Objectives: The purpose of this study was to assess the potential of late positive functional
remodeling after percutaneous pulmonary valve implantation (PPVI) in right ventricular …

The data describing the change in exercise capacity after surgical or interventional
management of the patient with right ventricular (RV) outflow tract (OT) dysfunction are …

Aims To assess the impact of relief of pulmonary stenosis (PS) and pulmonary regurgitation
(PR) by percutaneous pulmonary valve implantation (PPVI) on biventricular function during …

Aims To investigate the early clinical and physiological consequences of relieving chronic
right ventricular (RV) volume overload with percutaneous pulmonary valve implantation …

Background—Right ventricular outflow tract (RVOT) reconstruction with valved conduits in
infancy and childhood leads to reintervention for pulmonary regurgitation and stenosis in …

Background—Percutaneous pulmonary valve implantation (PPVI) is a safe, less invasive
alternative to surgical valve replacement for the congenital heart disease patient with right …

Aims Replacement of bioprosthetic valves in the right ventricular (RV) outflow tract (RVOT) is
inevitable due to acquired valvar dysfunction. Percutaneous pulmonary valve implantation …

Objectives: The aim of this study was to report long-term outcomes after percutaneous
pulmonary valve implantation (PPVI). Background: Excellent short-and mid-term results after …

BACKGROUND: Percutaneous pulmonary valve implantation (PPVI) has been introduced
as therapy for right ventricular (RV) to pulmonary artery conduit dysfunction in patients with …

OBJECTIVES Since percutaneous pulmonary valve implantation (PPVI) was introduced to
prolong the lifetime of surgically placed right ventricular to pulmonary artery conduits, valve …